Ipca Labs drug gets WHO pre-qualification

Indian drug maker Ipca Laboratories Ltd said on Wednesday its anti-malarial combination drug, artemether and lumefantrine, had been pre-qualified by the World Health Organization (WHO).                                           

WHO's pre-qualification product list is used by agencies of the United Nations and other organisations to guide them in their procurement decisions.